pfo pw
Name
pvr
Label
Pulmonary vascular resistance
Units
wood
Type
numeric
Visit number vs Pulmonary vascular resistance
N Mean StdDev Median Min Max Unknown Total
Baseline Visit 83 149.9 ± 36.4 141.1 94.1 273.9 86 169
Month-6 Follow-up Visit - - - - - - - -
Month-12 Follow-up Visit 37 141.9 ± 33.4 136.2 97.6 268.6 71 108
Treatment arm vs Pulmonary vascular resistance
Baseline Visit
N Mean StdDev Median Min Max Unknown Total
Total 83 149.9 ± 36.4 141.1 94.1 273.9 86 169
Conservative Medical Therapy (CMT) 22 154.6 ± 30.1 150.6 107.1 209.9 22 44
CMT + Sham CPAP 19 135.5 ± 40.3 122.2 96.9 273.9 23 42
CMT + Active CPAP 22 151.1 ± 35.2 150.1 101.6 260.8 20 42
CMT + Active CPAP + Motivational Enhancement 20 157.0 ± 39.1 152.7 94.1 215.3 21 41
Treatment arm vs Pulmonary vascular resistance
Month-12 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 37 141.9 ± 33.4 136.2 97.6 268.6 71 108
Conservative Medical Therapy (CMT) 14 148.4 ± 26.7 142.8 110.9 188.1 15 29
CMT + Sham CPAP 7 138.2 ± 16.6 137.8 118.4 165.5 20 27
CMT + Active CPAP 7 146.1 ± 58.8 119.8 102.4 268.6 19 26
CMT + Active CPAP + Motivational Enhancement 9 131.3 ± 29.1 124.3 97.6 190.2 17 26
Age at visit vs Pulmonary vascular resistance
Baseline Visit
N Mean StdDev Median Min Max Unknown Total
Total 83 149.9 ± 36.4 141.1 94.1 273.9 86 169
46.0 to 59.0 years 15 138.1 ± 28.9 126.3 113.8 199.7 28 43
59.0 to 66.0 years 18 142.9 ± 33.0 140.0 94.1 215.3 24 42
66.0 to 69.0 years 23 148.6 ± 26.2 146.7 96.9 210.8 19 42
70.0 to 76.0 years 27 162.2 ± 46.5 159.8 99.5 273.9 15 42
Age at visit vs Pulmonary vascular resistance
Month-12 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 37 141.9 ± 33.4 136.2 97.6 268.6 71 108
47.0 to 60.0 years 6 133.3 ± 31.6 128.9 97.6 190.2 21 27
60.0 to 66.0 years 6 129.0 ± 22.5 121.8 106.9 159.7 21 27
66.0 to 70.0 years 11 147.4 ± 43.9 136.9 102.4 268.6 16 27
71.0 to 77.0 years 14 146.8 ± 29.5 144.0 102.5 188.1 13 27
Gender vs Pulmonary vascular resistance
Baseline Visit
N Mean StdDev Median Min Max Unknown Total
Total 83 149.9 ± 36.4 141.1 94.1 273.9 86 169
Male 50 151.3 ± 31.3 142.5 99.5 215.3 60 110
Female 33 147.7 ± 43.5 139.3 94.1 273.9 26 59
Gender vs Pulmonary vascular resistance
Month-12 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 37 141.9 ± 33.4 136.2 97.6 268.6 71 108
Male 26 145.4 ± 36.4 138.7 97.6 268.6 46 72
Female 11 133.5 ± 24.4 131.8 102.5 183.4 25 36
Race vs Pulmonary vascular resistance
Baseline Visit
N Mean StdDev Median Min Max Unknown Total
Total 82 150.2 ± 36.6 141.2 94.1 273.9 86 168
White 74 150.7 ± 37.5 141.2 94.1 273.9 78 152
American Indian or Alaskan Native - - - - - - - -
Black or African American 5 152.3 ± 30.0 154.5 113.8 186.5 6 11
Asian 2 122.3 ± 22.8 122.3 106.2 138.5 2 4
Native Hawaiian or other Pacific islander - - - - - - - -
Other 1 153.3 - 153.3 153.3 153.3 - 1
Multiple - - - - - - - -
Race vs Pulmonary vascular resistance
Month-12 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 37 141.9 ± 33.4 136.2 97.6 268.6 71 108
White 32 140.5 ± 35.0 133.2 97.6 268.6 63 95
American Indian or Alaskan Native - - - - - - - -
Black or African American 3 151.3 ± 27.8 136.9 133.8 183.4 6 9
Asian 2 149.7 ± 14.2 149.7 139.7 159.7 1 3
Native Hawaiian or other Pacific islander - - - - - - - -
Other - - - - - - 1 1
Multiple - - - - - - - -